Home » Newsletters » BioWorld Asia

BioWorld Asia

July 28, 1999

View Archived Issues

Cerep, Bristol-Myers Align In Broad Deal Worth $43M

EU Debate, Confusion Continue Over Confined Use Of GMOs

Bacterium's Ability To Stimulate T Cells Could Lead To Vaccine

Ovarian Cancer Gene Therapy Enters Phase II/III in Germany

MolecularNature Focuses On Plant-Based Compounds

Canadian Start-Up Working On New Approach To Cancer

PPL Uses Gene Targeting To Produce Two Lambs

AdProTech Compound Shows Promise In Animal Models

Cortecs Gets Termination Milestone From Partner

Oxford Biomedica, Modex Enter Insulin-Delivery Deal

NiCox Starts Phase II Trial At Two Centers In France

Genset Isolates Genes Associated With Responses To Asthma Drug

Queensland Researchers Link Cancer Protein To Cholesterol

Animal Data Lead Researchers To Possible MG Therapeutic

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
GWAS identifies variant associated with diabetic retinopathy and susceptibility to T2D
BioWorld Science
Scientists at the University of Nottingham Ningbo China and collaborators aimed to identify genetic variants associated with diabetic retinopathy.